|
|
 |
|
Viewing report
|
|
|
|
New Cancer Therapeutics: An Analysis Of Current And Emerging Markets
Business Insights, Nov 2002, Pages: 252
In 2001, for the fourth year in a row, the Centers for Disease Control reported a decline in the death rate from cancer, with the most notable decreases in the death rates for breast cancer, prostate cancer, lung cancer, colon cancer and leukemia. This is due in no small part to improved treatments, including more effective prescription drugs. While the death rate from cancer is declining, the number of actual deaths is increasing because of an increasing population and longer life expectancy. The new management report New Cancer Therapeutics: An analysis of current and emerging markets, provides detailed analyses of current drugs and developing technologies to predict future market dynamics. The report also assesses the ability of the pharmaceutical sector to meet the significant unmet need that exists in oncology. The expert analysis of trends and forecasts in this report will help you to identify the areas from which you may the yield greatest returns on your R&D investments - saving you time and money.
Customers who bought this item also bought
Cancer Therapeutics Markets
Chemotherapy Market Insights, 2006-2016: A Critical Analysis of Cancer Research, Treatments, Pipelines, and Commercial Opportunities
New Concepts in Cancer Therapeutics
Cancer Therapeutics 2006: Market Dynamics and R&D Trends
Drug Targets for Breast Cancer
Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development
Cancer Therapy Worldwide Market Survey: Analysis and Forecast - Technology, Sales and Company Profiles
25+ Business Development and Innovation Opportunities in Cancer Medicine - 2001
|
|
|
|
